Navigating Lung Cancer Screening: Identifying and Engaging High Risk Individuals
CE Information
0.75 CME creditsCompletion Time
45 minutesAvailable Until
January 31, 2026Posted By
American Academy of CME
Navigate
Overview
Specialties
OncologySubspecialties
Oncology and Respiratory/PulmonologyClinical Topics
Lung CancerDespite the clear advantages of screening for early-stage, more treatable lung cancer, a surprisingly low percentage of eligible Americans undergo recommended screening. While current guidelines for lung cancer screening are largely consistent, the nuances in interpreting and applying these criteria to the patient in front of you can be perplexing, leading to lower screening rates. Utilizing clinical cases and related questions, this activity addresses these key points, offering guidance on how to identify high-risk patients suitable for screening. Additionally, it will provide strategies to facilitate shared decision-making with patients, focusing on a comprehensive discussion of the benefits and risks associated with screening.
Learning Objectives
At the conclusion of the webinar, learners should be better able to:
- Review the evidence supporting CT lung screening benefits for eligible individuals in high-risk categories
- Utilize current recommendations to identify candidates for lung cancer screening
- Determine next steps to obtaining lung cancer screening for eligible patients
- Identify and address barriers to lung cancer screening in eligible patients
- Assess care team management to lung cancer screening
Speakers
Co-founder, Multi-Disciplinary Thoracic Oncology Clinic
Director, Interventional Pulmonary Medicine
Director, Interventional Pulmonology Fellowship Program Director
Lahey Hospital & Medical Center
Carla Lamb, MD, FACP, FCCP, and the President of the American Association for Advanced Bronchology and Interventional Pulmonology. She is one of the co-founders of the Multi-Disciplinary Thoracic Oncology Clinic and Director of Interventional Pulmonary Medicine as well as the Interventional Pulmonology Fellowship Program Director at Lahey Hospital & Medical Center. Dr. Lamb is on the steering committee of the Lahey Lung Screening Program and Research committee as well as the member of the Founding Board of Directors for the Rescue Lung Society for CT Lung Screening. Dr. Lamb co–founded Women in Interventional Pulmonology. She is an internationally recognized educator, speaker and researcher in interventional pulmonology, lung cancer screening, early detection of lung cancer utilizing biomarker technology, minimally invasive diagnosis and management of pulmonary nodules, and gender differences in lung cancer. She has won numerous distinguished educator awards and is the recipient of the Pasquale Ciaglia award in Interventional Pulmonary, ALA Chadwick Award, and the Samuel Moschella Educator of the Year award. She is the pulmonary lead physician for development of the incidental lung nodule program for Beth Israel and Lahey Health. She is also participating as a principal investigator in the multi-center Nightingale study for nasal brush risk stratification of patients with indeterminant pulmonary nodules with history of tobacco use. Dr. Lamb has been the principal investigator for the multi-center rheoplasty trial for COPD and chronic bronchitis and Airflow 3 for COPD. She has served as the director and founder of the Lahey COPD bronchoscopic lung volume reduction program for emphysema. She has co-authored the American Thoracic Society/ American College of Chest Physicians policy statement on implementation of low-dose computed tomography lung cancer screening programs in clinical practice as well as the American College of Chest Physicians guidelines for endobronchial ultrasound bronchoscopy. She has served on the national Chest Bronchoscopy Simulation Task Force. She is associate director of simulation at Lahey Hospital & Medical Center and has developed numerous national and international bronchoscopy and thoracic procedure curriculum and procedure based guidelines in bronchoscopy, image guided thoracic procedure simulation training and interventional pulmonology training. Her work has led to validation of internationally adopted procedural assessment tools. She is both the director of the interventional pulmonary program and interventional pulmonary fellowship program at Lahey Hospital and Medical Center.
CE Information
This activity offers 0.75 CME credits to attendees.
Accredited by American Academy of CME.
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Faculty Educator/Planner Carla Lamb, MD, has no relevant relationships with ineligible companies to disclose.
All other planners and reviewers have no relevant financial relationships with ineligible companies to disclose.
This activity will not review off-label or investigational information.
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.
Log in and start activity